Novel approach reduces risk of cervical cancer

the ONA take:

Researchers describe a novel approach to preventing cervical cancer. The study findings showed a reduction in cervical cancer risk after removal of a discrete population of cervical cells called squamocolumnar junction (SCJ) cells. SCJ cells, which reside in cervical canal, have been implicated as the origins of cervical cancer. In the study, 131 women with cervical intraepithelial neoplasia had the SCJ cells removed from their cervix via a loop electrosurgical excision procedure. Follow-up was for up to 4 years, during which time 16 recurrences were identified. Four recurrences were identified at the follow-up visit and determined to be residual disease. The other 12 manifested after the first postoperative visit, and all were in the ectocervix or in mature metaplastic epithelium; none of the delayed recurrences had SCJ cells. The researchers emphasize that removing SCJ cells does not prevent cervical intraepithelial neoplasias nor does it prevent human papillomavirus (HPV) infection. However, it seems to alter recurrence patterns presumably by removing those cells most vulnerable to development more dangerous precancers.

Novel approach reduces risk of cervical cancer
Novel approach reduces risk of cervical cancer
A study published online in theInternational Journal of Cancerearlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after removal of a discrete population of cells in the cervix. The findings come from a study that looked at squamocolumnar junction cells, or SCJ cells.
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs